Published in Hypertension on November 20, 1980
Captopril in renovascular hypertension: long-term use in predicting surgical outcome. Br Med J (Clin Res Ed) (1982) 1.76
Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure. Br J Clin Pharmacol (1982) 1.19
Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone. Br Heart J (1983) 1.15
Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation. J R Soc Med (1981) 1.07
Renal and pulmonary effects of angiotensin converting enzyme inhibition in chronic hypoxic lung disease. Thorax (1989) 1.04
Captopril and atenolol combined with hydrochlorothiazide in essential hypertension. Br J Clin Pharmacol (1982) 1.00
Effect of captopril on renal function in patients with congestive heart failure. Br Heart J (1981) 0.98
Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantation. Transplantation (2011) 0.89
Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension. Drugs (1985) 0.85
The effects of cilazapril alone and in combination with frusemide in healthy subjects. Br J Clin Pharmacol (1989) 0.83
Effects of acute and chronic cilazapril treatment in spontaneously hypertensive rats. Br J Clin Pharmacol (1989) 0.79
Long-term captopril therapy in severe refractory congestive heart failure. Br J Clin Pharmacol (1982) 0.75
Inhibitors of angiotensin I converting enzyme for treating hypertension. Br Med J (1980) 0.75
Angiotensin-converting enzyme (ACE) inhibition. Therapeutic option for diabetic hypertensive patients. Drugs (1990) 0.75
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N Engl J Med (1978) 5.04
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
How common is white coat hypertension? JAMA (1988) 4.42
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Characterization of human prorenin expressed in mammalian cells from cloned cDNA. Proc Natl Acad Sci U S A (1986) 3.60
Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens (1994) 2.91
A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet (1977) 2.90
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation (1994) 2.50
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med (1986) 2.36
Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intern Med (1979) 2.31
Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis (1979) 2.29
Hyperuricemia in primary and renal hypertension. N Engl J Med (1966) 2.22
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med (1986) 2.04
Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med (1976) 1.98
Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects. Antimicrob Agents Chemother (1983) 1.92
The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int (1972) 1.87
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest (1986) 1.84
Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med (1979) 1.83
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med (1973) 1.82
An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med (1974) 1.82
Amiloride. A potassium-sparing natriuretic agent. Circulation (1968) 1.80
Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet (1973) 1.78
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med (1984) 1.76
Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med (1985) 1.75
Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med (1981) 1.75
Captopril kinetics. Clin Pharmacol Ther (1982) 1.74
Auxin Transport, Gibberellin, and Apical Dominance. Science (1965) 1.72
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation (1990) 1.72
Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA (1982) 1.68
Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol (1994) 1.67
Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol (1990) 1.65
Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med (1977) 1.64
Disposition of captopril in normal subjects. Clin Pharmacol Ther (1980) 1.64
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension (1994) 1.63
The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) (1974) 1.62
A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am J Hypertens (1988) 1.60
Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide. Nature (1984) 1.60
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation (1983) 1.60
Possible role of increased blood viscosity in the hemodynamics of systemic hypertension. Am J Cardiol (2000) 1.58
Atrial natriuretic factor: structure and functional properties. Kidney Int (1985) 1.56
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol (1986) 1.56
Salt and hypertension. Lancet (1984) 1.52
Relation between potassium balance and aldosterone secretion in normal subjects and in patients with hypertensive or renal tubular disease. J Clin Invest (1966) 1.51
Physiologic and clincical observations on furosemide and ethacrynic acid. Ann N Y Acad Sci (1966) 1.50
Impedance cardiography for determination of stroke index. J Appl Physiol (1976) 1.50
Oral contraceptives. Renin, aldosterone, and high blood pressure. JAMA (1967) 1.49
Divergent blood pressure responses during short-term sodium restriction in hypertension. Clin Pharmacol Ther (1980) 1.49
Natriuretic activity in plasma and urine of salt-loaded man and sheep. J Clin Invest (1969) 1.48
Hypertension and a tumor of the glomus jugulare region. Evidence for epinephrine biosynthesis. Am J Hypertens (1993) 1.47
Disparate patterns of aldosterone response during diuretic treatment of hypertension. Ann Intern Med (1977) 1.45
Cardiac arrest postoperatively in a patient infected with ascaris, the roundworm. Chest (1989) 1.43
Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs (1990) 1.43
Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation (1979) 1.42
What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension (1985) 1.42
The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest (1970) 1.42
Hypertension: steps forward and steps backward. The Joint National Committee fifth report. Arch Intern Med (1993) 1.42
Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypertens (1997) 1.41
Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet (1988) 1.40
Renin and prorenin: advances and declines in methodology. Clin Chem (1996) 1.40
Furosemide. A clinical evaluation of its diuretic action. Circulation (1966) 1.40
Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation (1990) 1.39